View More Recent Stories

Jul 7, 2021 08:00AM PreveCeutical Files International Patent Application for its Dynorphin Peptides
May 31, 2021 08:00AM PreveCeutical Provides Corporate Update
Aug 4, 2020 12:55PM PreveCeutical Prepares for Clinical Trials for its Sol-Gel COVID-19 Program
May 3, 2018 09:30AM Second Shipment of Dried Cannabis Materials Shipped to Pharmacy Australia Centre of Excellence by PreveCeutical’s Canadian Licensed Producer Partner for Novel Nose-to-Brain Drug Delivery Research
Mar 29, 2018 08:30AM Arrival of Aurora’s Cannabis Material at Pharmacy Australia Centre of Excellence
Mar 19, 2018 07:30AM Uptick Newswire’s “Stock Day” Podcast Hosts Stephen Van Deventer, Chairman and CEO of PreveCeutical Medical Inc.
Mar 16, 2018 09:00AM PreveCeutical Announces Incorporation of Australian Subsidiary to Support Ongoing Research Programs
Mar 13, 2018 08:00AM Aurora Cannabis Exports Dried Cannabis Flower and Oils to Australia for Novel Nose-to-Brain Drug Delivery Research by PreveCeutical
Feb 26, 2018 09:30AM PreveCeutical Announces Appointment of Dr. Maher Khaled as Director of International Operations
Jan 30, 2018 09:30AM PreveCeutical Signs Research and Option Agreement with UniQuest Pty Limited for Development of Non-Addictive Analgesic Peptides
Jan 15, 2018 03:05AM PreveCeutical Medical Inc. Now Accepts Bitcoin as a Payment Method
View More Recent Stories